A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Montefiore Medical Center
Astellas Pharma Inc
AbbVie
Eli Lilly and Company
OncoC4, Inc.
Jazz Pharmaceuticals
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Pfizer
Amgen
Arcus Biosciences, Inc.
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
UNC Lineberger Comprehensive Cancer Center
Duke University
University of California, San Diego
Baylor College of Medicine
SystImmune Inc.
Daiichi Sankyo
Takeda
Perspective Therapeutics
Second Life Therapeutics
M.D. Anderson Cancer Center
Novartis
Var2 Pharmaceuticals
VM Oncology, LLC
Tanabe Pharma America, Inc.
Mayo Clinic
NeoTX Therapeutics Ltd.
University of Connecticut
Tempus AI
Incyte Corporation
Immunitas Therapeutics
Actym Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan University
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Eli Lilly and Company
ModeX Therapeutics, An OPKO Health Company